Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization

Masaki Yamauchi, Eiichi Watanabe, Kenji Yasui, Hiroshi Takeuchi, Toshiaki Terasawa, Ken Sawada, Hitoshi Hishida, Itsuo Kodama

研究成果: Article

13 引用 (Scopus)

抄録

Backgrounds: Antiarrhythmic potential of mexiletine in patients with congenital and acquired long-QT syndrome (LQTS) has been attributed to a reduction of transmural dispersion of repolarization (TDR). A similar mechanism could be involved in the antiarrhythmic activity of the drug in patients with normal QT intervals, but the issue remains to be investigated. Methods and results: We analyzed 24-h Holter ECG recordings from 17 patients in sinus rhythm showing premature ventricular complexes (PVCs) with normal QT intervals (age, 62±10 years, mean±S.D.). Treatment of the patients with oral mexiletine (300 mg/day for 21-40 days) resulted in a significant reduction of PVCs (from 13899±18887 to 6949±12822 beats/24 h, p<0.01). Rate-dependent behavior of ventricular repolarization was analyzed by plotting QT intervals (QTpeak, QTend), and the interval from T-wave peak to T-wave end (TPE) against preceding respective RR intervals of sinus beats. Both the QTpeak and QTend tended to be shortened by mexiletine at RR intervals from 600 ms to 1000 ms, although the changes did not reach statistical significances. TPE, which reflects TDR, was shortened significantly at relatively long RR intervals (by 14±9% at RR of 900 ms, p<0.05). There was a linear relationship between the percentage shortening of TPE and the percentage reduction of PVCs (r=0.86, p<0.04). TPE≥70 ms was significantly associated with PVC suppression >75% with an odds ratio of 0.60 (95% confidence interval 0.36-0.98, per 1 ms increment). Conclusion: Inhibitory effect of mexiletine against PVCs in patients with normal QT intervals is mediated at least in part by a reduction of TDR. Mexiletine may be effective in patients exhibiting longer baseline TPE.

元の言語English
ページ(範囲)92-97
ページ数6
ジャーナルInternational Journal of Cardiology
103
発行部数1
DOI
出版物ステータスPublished - 03-08-2005

Fingerprint

Mexiletine
Ventricular Premature Complexes
Long QT Syndrome
Anti-Arrhythmia Agents
Electrocardiography
Odds Ratio
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用

Yamauchi, Masaki ; Watanabe, Eiichi ; Yasui, Kenji ; Takeuchi, Hiroshi ; Terasawa, Toshiaki ; Sawada, Ken ; Hishida, Hitoshi ; Kodama, Itsuo. / Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization. :: International Journal of Cardiology. 2005 ; 巻 103, 番号 1. pp. 92-97.
@article{f94f9fccbb934d239faf6e97197388b1,
title = "Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization",
abstract = "Backgrounds: Antiarrhythmic potential of mexiletine in patients with congenital and acquired long-QT syndrome (LQTS) has been attributed to a reduction of transmural dispersion of repolarization (TDR). A similar mechanism could be involved in the antiarrhythmic activity of the drug in patients with normal QT intervals, but the issue remains to be investigated. Methods and results: We analyzed 24-h Holter ECG recordings from 17 patients in sinus rhythm showing premature ventricular complexes (PVCs) with normal QT intervals (age, 62±10 years, mean±S.D.). Treatment of the patients with oral mexiletine (300 mg/day for 21-40 days) resulted in a significant reduction of PVCs (from 13899±18887 to 6949±12822 beats/24 h, p<0.01). Rate-dependent behavior of ventricular repolarization was analyzed by plotting QT intervals (QTpeak, QTend), and the interval from T-wave peak to T-wave end (TPE) against preceding respective RR intervals of sinus beats. Both the QTpeak and QTend tended to be shortened by mexiletine at RR intervals from 600 ms to 1000 ms, although the changes did not reach statistical significances. TPE, which reflects TDR, was shortened significantly at relatively long RR intervals (by 14±9{\%} at RR of 900 ms, p<0.05). There was a linear relationship between the percentage shortening of TPE and the percentage reduction of PVCs (r=0.86, p<0.04). TPE≥70 ms was significantly associated with PVC suppression >75{\%} with an odds ratio of 0.60 (95{\%} confidence interval 0.36-0.98, per 1 ms increment). Conclusion: Inhibitory effect of mexiletine against PVCs in patients with normal QT intervals is mediated at least in part by a reduction of TDR. Mexiletine may be effective in patients exhibiting longer baseline TPE.",
author = "Masaki Yamauchi and Eiichi Watanabe and Kenji Yasui and Hiroshi Takeuchi and Toshiaki Terasawa and Ken Sawada and Hitoshi Hishida and Itsuo Kodama",
year = "2005",
month = "8",
day = "3",
doi = "10.1016/j.ijcard.2004.09.016",
language = "English",
volume = "103",
pages = "92--97",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization. / Yamauchi, Masaki; Watanabe, Eiichi; Yasui, Kenji; Takeuchi, Hiroshi; Terasawa, Toshiaki; Sawada, Ken; Hishida, Hitoshi; Kodama, Itsuo.

:: International Journal of Cardiology, 巻 103, 番号 1, 03.08.2005, p. 92-97.

研究成果: Article

TY - JOUR

T1 - Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization

AU - Yamauchi, Masaki

AU - Watanabe, Eiichi

AU - Yasui, Kenji

AU - Takeuchi, Hiroshi

AU - Terasawa, Toshiaki

AU - Sawada, Ken

AU - Hishida, Hitoshi

AU - Kodama, Itsuo

PY - 2005/8/3

Y1 - 2005/8/3

N2 - Backgrounds: Antiarrhythmic potential of mexiletine in patients with congenital and acquired long-QT syndrome (LQTS) has been attributed to a reduction of transmural dispersion of repolarization (TDR). A similar mechanism could be involved in the antiarrhythmic activity of the drug in patients with normal QT intervals, but the issue remains to be investigated. Methods and results: We analyzed 24-h Holter ECG recordings from 17 patients in sinus rhythm showing premature ventricular complexes (PVCs) with normal QT intervals (age, 62±10 years, mean±S.D.). Treatment of the patients with oral mexiletine (300 mg/day for 21-40 days) resulted in a significant reduction of PVCs (from 13899±18887 to 6949±12822 beats/24 h, p<0.01). Rate-dependent behavior of ventricular repolarization was analyzed by plotting QT intervals (QTpeak, QTend), and the interval from T-wave peak to T-wave end (TPE) against preceding respective RR intervals of sinus beats. Both the QTpeak and QTend tended to be shortened by mexiletine at RR intervals from 600 ms to 1000 ms, although the changes did not reach statistical significances. TPE, which reflects TDR, was shortened significantly at relatively long RR intervals (by 14±9% at RR of 900 ms, p<0.05). There was a linear relationship between the percentage shortening of TPE and the percentage reduction of PVCs (r=0.86, p<0.04). TPE≥70 ms was significantly associated with PVC suppression >75% with an odds ratio of 0.60 (95% confidence interval 0.36-0.98, per 1 ms increment). Conclusion: Inhibitory effect of mexiletine against PVCs in patients with normal QT intervals is mediated at least in part by a reduction of TDR. Mexiletine may be effective in patients exhibiting longer baseline TPE.

AB - Backgrounds: Antiarrhythmic potential of mexiletine in patients with congenital and acquired long-QT syndrome (LQTS) has been attributed to a reduction of transmural dispersion of repolarization (TDR). A similar mechanism could be involved in the antiarrhythmic activity of the drug in patients with normal QT intervals, but the issue remains to be investigated. Methods and results: We analyzed 24-h Holter ECG recordings from 17 patients in sinus rhythm showing premature ventricular complexes (PVCs) with normal QT intervals (age, 62±10 years, mean±S.D.). Treatment of the patients with oral mexiletine (300 mg/day for 21-40 days) resulted in a significant reduction of PVCs (from 13899±18887 to 6949±12822 beats/24 h, p<0.01). Rate-dependent behavior of ventricular repolarization was analyzed by plotting QT intervals (QTpeak, QTend), and the interval from T-wave peak to T-wave end (TPE) against preceding respective RR intervals of sinus beats. Both the QTpeak and QTend tended to be shortened by mexiletine at RR intervals from 600 ms to 1000 ms, although the changes did not reach statistical significances. TPE, which reflects TDR, was shortened significantly at relatively long RR intervals (by 14±9% at RR of 900 ms, p<0.05). There was a linear relationship between the percentage shortening of TPE and the percentage reduction of PVCs (r=0.86, p<0.04). TPE≥70 ms was significantly associated with PVC suppression >75% with an odds ratio of 0.60 (95% confidence interval 0.36-0.98, per 1 ms increment). Conclusion: Inhibitory effect of mexiletine against PVCs in patients with normal QT intervals is mediated at least in part by a reduction of TDR. Mexiletine may be effective in patients exhibiting longer baseline TPE.

UR - http://www.scopus.com/inward/record.url?scp=23044432738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044432738&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2004.09.016

DO - 10.1016/j.ijcard.2004.09.016

M3 - Article

C2 - 16061129

AN - SCOPUS:23044432738

VL - 103

SP - 92

EP - 97

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -